Stock Analysis
Mondelez International, Inc. (MDLZ) Stock Analysis
Mondelez International, Inc. (MDLZ) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Mondelez International, Inc. (MDLZ) currently has an AIQ Score of 44/100, indicating a neutral setup. Risk is the strongest factor at 51/100. Value is the weakest current factor at 37/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
MDLZ at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $62.44 |
| AIQ Score | 44/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Neutral |
| Market Cap | $78.63B |
| P/E Ratio | 21.62 |
| Forward P/E | — |
| EPS | $1.20 |
| Revenue TTM | $9.36B |
| Dividend Yield | 0.01% |
| Beta | 0.4 |
| Volume | 5.6M |
| 52-week range | $51.20-$66.65 |
| RSI 14 | 34.8 |
| 50-Day SMA | $61.74 |
| 200-Day SMA | $59.22 |
| Analyst Price Target | $69.40 |
| Next Earnings | Oct 27, 2026 |
MDLZ
OverviewMDLZ Stock Analysis Summary
Mondelez International, Inc. (MDLZ) currently has an AIQ Score of 44/100, indicating a neutral setup. Risk resilience is the strongest factor at 51/100. Value is the weakest current factor at 37/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, MDLZ has AIQ Score of 44/100 with Risk resilience base of 51/100 and fading Value at 37/100. Wait for component alignment before adding exposure.
Consumer Defensive · -0.05% stock move · MDLZ classified in Food Confectioners.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is MDLZ Bullish or Bearish Right Now?
MDLZ currently has a neutral overall setup. Risk Resilience is the strongest factor at 51/100, while Value is weakest at 37/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Price is +1.13% above its 50-day SMA.
- - Analyst target implies +11.15% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (19 vs 17).
- - Value is the current constraint at 37/100.
Current Consensus
MDLZ's Technical Analysis Consensus is currently Neutral, with 19 buy, 9 neutral, and 17 sell votes. MDLZ's 14-day RSI is 34.8, which places the stock in a weaker momentum range. MDLZ's beta is 0.4, indicating lower market sensitivity than the broad market.
What Changed in MDLZ?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the MDLZ Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
MDLZ Decision Framework
Public evidence layers, setup checks, and risk context for Mondelez International, Inc..
Mondelez International, Inc. (MDLZ) Stock Analysis
Mondelez International, Inc. has an AIQ Score of 44/100 in a Neutral regime. Risk is strongest at 51/100. Beta is 0.4, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | MDLZ is in a Neutral AIQ regime with score 44/100. |
| Signal Conflict | The primary conflict is that risk leads at 51/100 while value lags at 37/100. |
| Factor Evidence | Momentum 49/100 · Value 37/100 · Quality 45/100 · Risk 51/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Risk is the strongest factor at 51/100.
Momentum is 49/100 and RSI (14) is 34.8.
MDLZ is in a Neutral regime at 44/100.
Risk factor is 51/100 with beta 0.4 and annual volatility 23.41%.
Current conflict: risk leads at 51/100 while value lags at 37/100.
MDLZ Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
MDLZ Fundamentals
MDLZ valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
MDLZ Technical Analysis
MDLZ technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
MDLZ Stock Catalysts
Track MDLZ earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
MDLZ Dividend Analysis
MDLZ dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
MDLZ Financial Data
MDLZ revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
MDLZ Risk Analysis
MDLZ volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
MDLZ Stock News
MDLZ stock news, market tone, recent headlines, and catalyst context.
MDLZ vs Consumer Staples Peers
Current peer cohort: MDLZ · MKC · MNST · MO · NWL. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| MDLZ Current stock | 44/100 | 37/100 | 49/100 | 51/100 | -0.04 | 23.41% | Current |
| MKC McCormick | 46/100 | 44/100 | 23/100 | 53/100 | -0.94 | 30.23% | MDLZ vs MKC |
| MNST Monster Beverage | 48/100 | 24/100 | 29/100 | 63/100 | 0.72 | 114.16% | MDLZ vs MNST |
| MO Altria Group | 54/100 | 48/100 | 61/100 | 41/100 | 0.14 | 26.39% | MDLZ vs MO |
| NWL Newell Brands | 45/100 | 68/100 | 56/100 | 36/100 | 0.18 | 59.28% | MDLZ vs NWL |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts7 recent quarterly periods are available for review.
Checked Sep 11, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching MDLZ
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for MDLZ
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
MDLZ Stock FAQ
What is MDLZ stock price today?
Mondelez International, Inc.'s current stock price is $62.44. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is MDLZ bullish or bearish right now?
MDLZ's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is MDLZ's market cap?
MDLZ's market cap is $78.63B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is MDLZ's current P/E ratio?
MDLZ's current P/E ratio is 21.62 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is MDLZ's RSI?
MDLZ's 14-day RSI is 34.8 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is MDLZ above its 50-day and 200-day moving averages?
MDLZ is 1.13% from its 50-day SMA and 5.43% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is MDLZ's next earnings date?
MDLZ's next earnings date is currently listed as Oct 27, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does MDLZ pay a dividend?
MDLZ's dividend yield is 0.01% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.